CapsoVision (CV) furnishes Q2 2025 earnings press release in 8-K

Rhea-AI Filing Summary

CapsoVision, Inc. filed a current report to note that it issued a press release on August 14, 2025 announcing its financial results for the fiscal quarter ended June 30, 2025. The company is using this filing to formally furnish that earnings press release as Exhibit 99.1.

The earnings information in the press release is furnished rather than filed, which means it is not automatically incorporated into other securities law filings unless specifically referenced later. The report also identifies the company’s common stock as trading on The Nasdaq Stock Market LLC under the symbol CV.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

FALSE000137832500013783252025-08-142025-08-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

_________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2025

_________________________

CapsoVision, Inc.

(Exact name of registrant as specified in its charter)

_________________________

Delaware

001-42705

20-3369494

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification Number)

18805 Cox Avenue, Suite 250 Saratoga, California						95070
(Address of Principal Executive Offices)						(Zip Code)

Registrant’s telephone number, including area code: (408)-624-1488

n/a

(Former Name or Former Address, if Changed Since Last Report)

_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

common stock, $0.001 par value per share

CV

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.           Results of Operations and Financial Condition.

On August 14, 2025, the Company issued a press release announcing its financial results for the fiscal quarter ended June 30, 2025. A copy of the press release, dated August 14, 2025, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

The foregoing information in this Item 2.02 (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01           Financial Statements and Exhibits.

The following exhibits are being filed herewith:

Exhibit No.						Description
99.1						Press Release of CapsoVision, Inc, dated August 14, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			CAPSOVISION, INC.
Date: August 14, 2025			By:			/s/ Kevin Lundquist
			Name:			Kevin Lundquist
			Title			Chief Financial Officer

FAQ

What did CapsoVision, Inc. (CV) report in this 8-K?

CapsoVision, Inc. reported that it issued a press release on August 14, 2025 announcing its financial results for the fiscal quarter ended June 30, 2025, and furnished that release as Exhibit 99.1.

Which period’s results does CapsoVision’s August 14, 2025 press release cover?

The press release furnished with this report covers CapsoVision’s financial results for the fiscal quarter ended June 30, 2025.

How is the CapsoVision (CV) earnings press release treated under securities laws?

The earnings press release attached as Exhibit 99.1 is furnished under Item 2.02 and is expressly not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated into Securities Act filings unless specifically referenced.

What exhibits are included with this CapsoVision 8-K?

The report includes Exhibit 99.1, which is the CapsoVision, Inc. press release dated August 14, 2025, and Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.

Who signed the CapsoVision August 14, 2025 8-K?

The report was signed on behalf of CapsoVision, Inc. by Kevin Lundquist, its Chief Financial Officer.

On which exchange is CapsoVision, Inc. common stock listed and under what symbol?

CapsoVision, Inc. common stock, with a par value of $0.001 per share, is listed on The Nasdaq Stock Market LLC under the trading symbol CV.